UBF Inhibitors

Common UBF Inhibitors include, but are not limited to Actinomycin D CAS 50-76-0, Fluorouracil CAS 51-21-8, α-Amanitin CAS 23109-05-9, Camptothecin CAS 7689-03-4 and Mitoxantrone CAS 65271-80-9.

UBF, or Upstream Binding Factor, is a pivotal protein in the nucleolus of eukaryotic cells. Primarily known for its role in the transcription of ribosomal RNA (rRNA) genes, UBF plays a central role in the formation and functioning of the nucleolus. It is a member of the high mobility group (HMG) protein family, characterized by containing HMG-box domains that allow for DNA binding. Through its DNA-binding capability, UBF is able to recognize and bind to the upstream control element (UCE) and the core promoter region of the rRNA genes, thereby initiating the transcription process. UBF acts in collaboration with the RNA polymerase I (Pol I) machinery, ensuring efficient and high-level transcription of rRNA genes, a process essential for ribosome biogenesis and, consequently, protein synthesis.

UBF Inhibitors comprise a class of chemical compounds designed to specifically target and hinder the activity or function of UBF. By inhibiting UBF, these compounds can modulate the transcription of rRNA genes and, subsequently, influence ribosome biogenesis. Such inhibitors may function by blocking the DNA-binding capability of UBF, stopping its interaction with other components of the Pol I machinery, or disrupting its conformation or post-translational modifications essential for its activity. Given the importance of UBF in ribosome production and cellular protein synthesis, UBF inhibitors significantly impact cellular growth and proliferation. Delving into the specific mechanisms and characteristics of these inhibitors provides valuable insights into the intricate processes of ribosome biogenesis and the broader landscape of gene transcription in the cell.